Cango Inc. Reports Third Quarter 2025 Unaudited Financial Results
DALLAS, Dec. 2, 2025 /PRNewswire/ -- On December 1, Cango Inc. (NYSE:…
PDF Solutions to Make Its Analyst Day Webcast and Presentation Available
Company Also Reaffirms 2025 Financial Outlook December 01, 2025 19:01 ET |…
TAP Sleep Care Secures Full Medicare Portfolio Coverage: Nylon flexTAP Receives PDAC Approval under E0486
December 01, 2025 12:10 ET | Source: Airway Management, Inc. DALLAS, Dec.…
Fovia AI to Showcase Universal AI Viewer and Seamless Reporting Integrations at Radiology Reimagined Exhibit, RSNA 2025
AI, Innovation and Real‑World Interoperability Demonstrations CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE)…
Fusemachines Files Q3 2025 Quarterly Report and Discloses Nasdaq Notice
November 28, 2025 16:05 ET | Source: Fusemachines NEW YORK, Nov. 28,…
Spirit Blockchain Capital Files Q3 2025 Financial Statements and Announces CFO Transition
November 28, 2025 19:30 ET | Source: Spirit Blockchain Capital Inc. Vancouver,…
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
November 28, 2025 20:13 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Algernon Closes Second Tranche of Private Placement Financing
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
BIGG Digital Assets Inc. Reports Financial Results for Q3 2025
VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets…
Eisai Submits New Drug Application for Subcutaneous Formulation of LEQEMBI for the Treatment of Early Alzheimers Disease in Japan
If approved, lecanemab would be the first and only anti-amyloid treatment in…